GAD
9 drugs in development·7 companies·1 clinical trial
Drug Pipeline by Phase
Approved(5)
Phase 2(1)
| Drug | Company |
|---|---|
| antidepressant therapy | AbbVie Inc. (ABBV) |
Phase 1(1)
| Drug | Company |
|---|---|
| ABBV-932 | AbbVie Inc. (ABBV) |
Unknown(1)
| Drug | Company |
|---|---|
| PluriPain® | BIOADAPTIVES, INC. (BDPT) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for GAD?
BioSniper tracks 9 drugs in development for GAD across 7 companies.
How many clinical trials target GAD?
There are 1 clinical trial targeting GAD tracked by BioSniper.
Deep-dive into GAD
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis